Benzinga's Top Downgrades

Analysts at Goldman Sachs downgraded Vitamin Shoppe

from Buy to Neutral. The price target for Vitamin Shoppe has been lowered from $49 to $48. Vitamin Shoppe's shares closed at $47.07 yesterday. Analysts at Bank of America downgraded Aflac

from Buy to Neutral. The price target for Aflac is set to $66. Aflac's shares closed at $59.53 yesterday. Analysts at Stifel Nicolaus downgraded Salix Pharmaceuticals

from Buy to Hold and removed the price target of $189. Salix Pharmaceuticals' shares closed at $138.55 yesterday. Analysts at Susquehanna downgraded L Brands

from Positive to Neutral. L Brands' shares closed at $76.35 yesterday.